Oak Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.96M Buy
89,822
+7,499
+9% +$831K 0.65% 37
2025
Q1
$9.22M Sell
82,323
-45
-0.1% -$5.04K 0.69% 39
2024
Q4
$7.61M Sell
82,368
-737
-0.9% -$68.1K 0.52% 40
2024
Q3
$6.97M Buy
83,105
+424
+0.5% +$35.5K 0.47% 45
2024
Q2
$5.67M Sell
82,681
-902
-1% -$61.9K 0.38% 45
2024
Q1
$6.12M Sell
83,583
-692
-0.8% -$50.7K 0.42% 46
2023
Q4
$6.83M Sell
84,275
-503
-0.6% -$40.7K 0.52% 45
2023
Q3
$6.35M Sell
84,778
-2,079
-2% -$156K 0.53% 43
2023
Q2
$6.69M Sell
86,857
-31,868
-27% -$2.46M 0.54% 43
2023
Q1
$9.85M Sell
118,725
-10,509
-8% -$872K 0.81% 38
2022
Q4
$11.1M Buy
129,234
+2,741
+2% +$235K 0.93% 34
2022
Q3
$7.8M Buy
126,493
+7,436
+6% +$459K 0.66% 39
2022
Q2
$7.36M Sell
119,057
-1,609
-1% -$99.5K 0.58% 40
2022
Q1
$7.17M Sell
120,666
-11,612
-9% -$690K 0.44% 45
2021
Q4
$9.61M Sell
132,278
-3,777
-3% -$274K 0.51% 41
2021
Q3
$9.5M Buy
136,055
+7
+0% +$489 0.54% 44
2021
Q2
$9.37M Sell
136,048
-2,181
-2% -$150K 0.53% 44
2021
Q1
$8.93M Buy
138,229
+20,289
+17% +$1.31M 0.53% 43
2020
Q4
$6.87M Sell
117,940
-180,120
-60% -$10.5M 0.42% 50
2020
Q3
$18.8M Sell
298,060
-33,479
-10% -$2.12M 1.26% 25
2020
Q2
$25.5M Sell
331,539
-4,114
-1% -$317K 1.71% 16
2020
Q1
$25.1M Buy
335,653
+1,976
+0.6% +$148K 2.06% 14
2019
Q4
$21.7M Sell
333,677
-11,086
-3% -$720K 1.28% 29
2019
Q3
$21.9M Buy
344,763
+5,339
+2% +$338K 1.35% 26
2019
Q2
$22.9M Buy
339,424
+523
+0.2% +$35.3K 1.43% 22
2019
Q1
$22M Buy
338,901
+43,032
+15% +$2.8M 1.35% 26
2018
Q4
$18.5M Buy
295,869
+61,375
+26% +$3.84M 1.3% 24
2018
Q3
$18.1M Buy
234,494
+26,103
+13% +$2.02M 1.11% 29
2018
Q2
$14.8M Buy
208,391
+8,491
+4% +$601K 0.99% 34
2018
Q1
$15.1M Buy
199,900
+195,600
+4,549% +$14.7M 1.05% 32
2017
Q4
$308K Buy
4,300
+1,715
+66% +$123K 0.02% 149
2017
Q3
$209K Buy
+2,585
New +$209K 0.02% 158